Skip to main content
. 2024 Aug 27;40(3-4):275–283. doi: 10.3233/CBM-230458

Table 3.

Frequency of cometylation of the promoter regions of BRCA1 and BRCA2 genes in the study groups

Combined hypermethylation Control, blood samples (n= 62) BC, blood samples (n= 74) BC, tumour samples (n= 74)
BRCA1 UU +BRCA2 UU 57 (91.9%) 55 (74.3%) 31 (41.9%)
BRCA1 MU +BRCA2 UU 2 (3.2%) 7 (9.5%) 12 (16.2%)
BRCA1 UU +BRCA2 MU 3 (4.8%) 10 (13.5%) 17 (23.0%)
BRCA1 MU +BRCA2 MU 0 (0.0%) 2 (2.7%) 14 (18.9%)

M – methylated; U – unmethylated.